These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6979361)

  • 1. Enzymatic activities of activated and zymogen forms of human Hageman factor (factor XII).
    Silverberg M; Kaplan AP
    Blood; 1982 Jul; 60(1):64-70. PubMed ID: 6979361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The autoactivation of rabbit Hageman factor.
    Wiggins RC; Cochrane CC
    J Exp Med; 1979 Nov; 150(5):1122-33. PubMed ID: 501286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfatide-dependent autoactivation of human blood coagulation Factor XII (Hageman Factor).
    Tans G; Rosing J; Griffin JH
    J Biol Chem; 1983 Jul; 258(13):8215-22. PubMed ID: 6553053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
    Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis.
    Mandle R; Kaplan AP
    J Biol Chem; 1977 Sep; 252(17):6097-104. PubMed ID: 408348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein.
    Kaplan AP; Kay AB; Austen KF
    J Exp Med; 1972 Jan; 135(1):81-97. PubMed ID: 5009705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial cells produce a substance that inhibits contact activation of coagulation by blocking the activation of Hageman factor.
    Kleniewski J; Donaldson VH
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):198-202. PubMed ID: 8419923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
    Revak SD; Cochrane CG; Griffin JH
    J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Hageman factor activation in human plasma: quantification of activated Hageman factor-C1 inactivator complexes by an enzyme-linked differential antibody immunosorbent assay.
    Kaplan AP; Gruber B; Harpel PC
    Blood; 1985 Sep; 66(3):636-41. PubMed ID: 3875374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
    Tans G; Janssen-Claessen T; Rosing J; Griffin JH
    Eur J Biochem; 1987 May; 164(3):637-42. PubMed ID: 3552674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor).
    Cochrane CG; Wuepper KD
    J Exp Med; 1971 Oct; 134(4):986-1004. PubMed ID: 4106492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cleavage and formation of activated human Hageman factor by autodigestion and by kallikrein.
    Dunn JT; Silverberg M; Kaplan AP
    J Biol Chem; 1982 Feb; 257(4):1779-84. PubMed ID: 6915937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation and structure of human Hageman factor fragments.
    Dunn JT; Kaplan AP
    J Clin Invest; 1982 Sep; 70(3):627-31. PubMed ID: 6921203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of C1 inhibitor upon Hageman factor autoactivation.
    Weiss R; Silverberg M; Kaplan AP
    Blood; 1986 Jul; 68(1):239-43. PubMed ID: 3487356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hageman factor-dependent system in the vascular permeability reaction.
    Yamamoto T; Kozono K; Kambara T; Cochrane CG
    Biochim Biophys Acta; 1988 Aug; 966(2):196-206. PubMed ID: 3401504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.
    Meier HL; Pierce JV; Colman RW; Kaplan AP
    J Clin Invest; 1977 Jul; 60(1):18-31. PubMed ID: 874082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Hageman factor (factor XII) by popcorn inhibitor.
    Kambhu SA; Ratnoff OD; Everson B
    J Lab Clin Med; 1985 May; 105(5):625-8. PubMed ID: 3989356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluid phase activation of Hageman factor (factor XII) in citrated human plasma by bromelain: an application to the indirect enzymatic assay for Hageman factor.
    Oh-ishi S
    Thromb Res; 1982 Sep; 27(5):619-23. PubMed ID: 6983741
    [No Abstract]   [Full Text] [Related]  

  • 20. Human plasma prekallikrein. Studies of its activation by activated factor XII and of its inactivation by diisopropyl phosphofluoridate.
    Bouma BN; Miles LA; Beretta G; Griffin JH
    Biochemistry; 1980 Mar; 19(6):1151-60. PubMed ID: 6768384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.